Practice guideline for the surveillance of patients after curative treatment of colon and rectal cancer

Diseases of the Colon and Rectum

Volumn 58, Issue 8, 2015, Pages 717-725

  Steele, Scott R ^a   Chang, George J ^a   Hendren, Samantha ^a   Weiser, Marty ^a   Irani, Jennifer ^a   Buie, W Donald ^a   Rafferty, Janice F ^a  

^a NONE

Author keywords

Colon cancer; Endoscopy; Neoplasm; Radiology; Rectal cancer; Surveillance

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; AMBULATORY CARE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; ENDOSCOPIC SURGERY; HUMAN; LOCAL EXCISION; META ANALYSIS (TOPIC); OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; RECTUM ANASTOMOSIS; RECTUM ANTERIOR RESECTION; RECTUM CANCER; SIGMOIDOSCOPY; ABDOMINAL SURGERY; ADENOCARCINOMA; BLOOD; CHEMORADIOTHERAPY; COLON RESECTION; COLORECTAL NEOPLASMS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPY; NEOPLASM RECURRENCE, LOCAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT COMPLIANCE; RECTUM; SURGERY;

ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDOSCOPY; ENDOSONOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT COMPLIANCE; RECTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937676063     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000410     Document Type: Article

References (100)

1. American Cancer Society. American Cancer Society. Colorectal Cancer Facts & Figures: 2011-2013. Atlanta, GA: American Cancer Society; 2011. Available at: http://www.cancer.org/acs/.groups/content/@epidemiologysurveilance/documents/document/.acspc-028312.pdf Accessed April 29, 2014
2. Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-Analysis. Dis Colon Rectum. 2007; 50: 1783-1799
3. Rex DK, Kahi CJ, Levin B, et al. American Cancer Society; US Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006; 130: 1865-1871
4. Desch CE, Benson AB 3rd, Somerfield MR, et al. American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005; 23: 8512-8519
5. Scholl HJ, VanCutsem E, Stein A, et al. ESMO Consensus guidelines for the management of patients with colon and rectal cancer: a personalized approach to clinical decision making. Ann Oncol. 2012; 23: 2479-2516
6. Poston GJ, Tait D, O'Connell S, et al. Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ. 2011; 343: 1-4
7. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer. Version 3.2014, January 27, 2014. Available at: http://www.nccn.org/professionals/physician-gls/.PDF/colon.pdf. Accessed April 29, 2014
8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Rectal Cancer. Version 3.2014, January 27, 2014. Available at: http://www.nccn.org/professionals/physician-gls/.PDF/rectal.pdf. Accessed April 29, 2014
9. Anthony T, Simmang C, Hyman N, et al. Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and followup of patients with colon and rectal cancer. Dis Colon Rectum. 2004; 47: 807-817
10. Meyerhardt JA, Mangu PB, Flynn PJ, et al. American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013; 31: 4465-4470
11. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg K. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum. 1995; 38: 619-626
12. Makela JT, Seppo OL, Kairaluoma MI. Five-year followup after radical surgery for colorectal cancer. Arch Surg. 1995; 130: 1062-1067
13. Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997; 84: 666-669
14. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol. 1999; 34: 509-515
15. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998; 114: 7-14
16. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum. 1998; 41: 1127-1133
17. Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-Adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002; 28: 418-423
18. Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-The GILDA trial. Surg Oncol. 2004; 13: 119-124
19. Wattchow DA, Weller DP, Esterman A, et al. General practice vs. follow-up for patients with colon cancer: randomized controlled trial. Br J Cancer. 2006; 94: 1116-1121
20. Rodríguez-Moranta F, Saló J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006; 24: 386-393
21. Wang T, Cui Y, Huang WS, et al. The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study. Gastrointest Endosc. 2009; 69(3 pt 2): 609-615
22. Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FA CS randomized clinical trial. JAMA. 2014; 311: 263-270
23. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer: a meta-Analysis. Ann Surg. 1994; 219: 174-182
24. Rosen M, Chan L, Beart RW Jr, Vukasin P, Anthone G. Followup of colorectal cancer: a meta-Analysis. Dis Colon Rectum. 1998; 41: 1116-1126
25. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database of Syst Rev. 2002(1): CD002200
26. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-Analysis of randomised trials. BMJ. 2002; 324: 813
27. Figueredo A, Rumble RB, Maroun J, et al. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003; 3: 26
28. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007(1): CD002200
29. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844-857
30. Davila RE, Rajan E, Baron TH, et al. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006; 63: 546-557
31. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006; 129: 174-181
32. GILDA (Gruppo Italiano di Lavoro per la Diagnosi Anticipata) A multicentre randomized trial of intensive versus minimalist strategy in the follow-up of patients with resected Dukes B-C colorectal carcinoma (trial protocol). Available at: http://crc. marionegri.it/protocols/protocol.pdf. Accessed February 2014
33. COLOFOL . Study protocol A pragmatic study to assess the frequency of surveillance tests after curative resection in patients with stage II and III colorectal cancer - A randomised multicentre trial. Available at: www.colofol.com/html/download/.COLOFOL-7-5.pdf. Accessed February 2014
34. Earle C, Annis R, Sussman J, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer A quality initiative of the program in evidencebased care (PEBC), Cancer Care Ontario (CCO). February 3, 2012. Available at: https: //www.cancercare.on.ca/common/pages/.UserFile.aspx?fileId=124837. Accessed April 29, 2014
35. Frankel TL, D'Angelica MI. Hepatic resection for colorectal metastases. J Surg Oncol. 2014; 109: 2-7
36. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009; 27: 3677-3683
37. Neeff H, Hörth W, Makowiec F, et al. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009; 13: 1813-1820
38. Shah SA, Haddad R, Al-Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg. 2006; 202: 468-475
39. Tsikitis VL, Malireddy K, Green EA, et al. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009; 27: 3671-3676
40. Russell MC, You YN, Hu CY, et al A novel risk-Adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013; 148: 769-777
41. Johnston CF, Tomlinson G, Temple LK, Baxter NN. The management of patients with T1 adenocarcinoma of the low rectum: a decision analysis. Dis Colon Rectum. 2013; 56: 400-407
42. Tong LL, Gao P, Wang ZN, et al. Is pT2 subclassification feasible to predict patient outcome in colorectal cancer? Ann Surg Oncol. 2011; 18: 1389-1396
43. Tsai HL, Chu KS, Huang YH, et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol. 2009; 100: 736-743
44. Blumberg D, Paty PB, Picon AI, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg. 1998; 186: 574-579
45. Nash GM, Weiser MR, Guillem JG, et al. Long-Term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum. 2009; 52: 577-582
46. Endreseth BH, Myrvold HE, Romundstad P, Hestvik UE, Bjerkeset T, Wibe A; Norwegian Rectal Cancer Group. Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum. 2005; 48: 1380-1388
47. Heafner TA , Glasgow SC A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol. 2014; 5: 345-352
48. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, García-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000; 43: 1064-1071
49. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg. 1998; 228: 59-63
50. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998; 129: 27-35
51. Sargent DJ, Patiyil S, Yothers G, et al. ACCENT Group. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20, 898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol. 2007; 25: 4569-4574
52. Tan KK, Lopes Gde L Jr, Sim R. How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg. 2009; 13: 642-648
53. Sadahiro S, Suzuki T, Ishikawa K, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology. 2003; 50: 1362-1366
54. Nordholm-Carstensen A, Krarup PM, Jorgensen LN, Wille-Jørgensen PA, Harling H; Danish Colorectal Cancer Group. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study. Eur J Cancer. 2014; 50: 447-456
55. Blackmon SH, Stephens EH, Correa AM, et al. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg. 2012; 94: 1802-1809
56. Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel: a prospective study. Am J Surg. 1984; 147: 330-333
57. Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum. 1996; 39: 329-334
58. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993; 328: 901-906
59. Barillari P, Ramacciato G, Manetti G, Bovino A, Sammartino P, Stipa V. Surveillance of colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum. 1996; 39: 388-393
60. Brady PG, Straker RJ, Goldschmid S. Surveillance colonoscopy after resection for colon carcinoma. South Med J. 1990; 83: 765-768
61. Mäkelä J, Laitinen S, Kairaluoma MI. Early results of follow-up after radical resection for colorectal cancer. Preliminary results of a prospective randomized trial. Surg Oncol. 1992; 1: 157-161
62. Chen F, Stuart M. Colonoscopic follow-up of colorectal carcinoma. Dis Colon Rectum. 1994; 37: 568-572
63. Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002; 136: 261-269
64. Battersby NJ, Coupland A, Bouliotis G, Mirza N, Williams JG. Metachronous colorectal cancer: a competing risks analysis with consideration for a stratified approach to surveillance colonoscopy. J Surg Oncol. 2014; 109: 445-450
65. Ko C, Hyman NH. Practice parameter for the detection of colorectal neoplasms: an interim analysis. Dis Colon Rectum. 2006; 49: 299-301
66. Whitehouse PA, Armitage JN, Tilney HS, Simson JN. Transanal endoscopic microsurgery: local recurrence rate following resection of rectal cancer. Colorectal Dis. 2008; 10: 187-193
67. Sajid MS, Farag S, Leung P, Sains P, Miles WF, Baig MK. Systematic review and meta-Analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Dis. 2014; 16: 2-14
68. Sgourakis G, Lanitis S, Gockel I, et al. Transanal endoscopic microsurgery for T1 and T2 rectal cancers: a meta-Analysis and meta-regression analysis of outcomes. Am Surg. 2011; 77: 761-772
69. Rullier E, Denost Q, Vendrely V, Rullier A, Laurent C. Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum. 2013; 56: 560-567
70. Peng JY, Li ZN, Wang Y. Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers. World J Gastroenterol. 2013; 19: 5227-5237
71. Kusters M, Marijnen CA, van de Velde CJ, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; 36: 470-476
72. Kusters M, Beets GL, van de Velde CJ, et al A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009; 249: 229-235
73. de Anda EH, Lee SH, Finne CO, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Endorectal ultrasound in the follow-up of rectal cancer patients treated by local excision or radical surgery. Dis Colon Rectum. 2004; 47: 818-824
74. Löhnert MS, Doniec JM, Henne-Bruns D. Effectiveness of endoluminal sonography in the identification of occult local rectal cancer recurrences. Dis Colon Rectum. 2000; 43: 483-491
75. Im YC, Kim CW, Park S, Kim JC. Oncologic outcomes and proper surveillance after local excision of rectal cancer. J Korean Surg Soc. 2013; 84: 94-100
76. Morken JJ, Baxter NN, Madoff RD, Finne CO 3rd. Endorectal ultrasound-directed biopsy: a useful technique to detect local recurrence of rectal cancer. Int J Colorectal Dis. 2006; 21: 258-264
77. Ramirez JM, Mortensen NJ, Takeuchi N, Humphreys MM. Endoluminal ultrasonography in the follow-up of patients with rectal cancer. Br J Surg. 1994; 81: 692-694
78. Patel SA, Chen YH, Hornick JL, et al. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum. 2014; 57: 449-459
79. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg. 2004; 240: 260-268
80. Jeyarajah S, Sutton CD, Miller AS, Hemingway D; Leicester Colorectal Specialist Group. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis. 2007; 9: 808-815
81. Madbouly KM, Hussein AM, Abdelzaher E. Long-Term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer. Am J Surg. 2014; 208: 332-341
82. Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012; 30: 1770-1776
83. Gleeson FC, Larson DW, Dozois EJ, et al. Local recurrence detection following transanal excision facilitated by EUS-FNA . Hepatogastroenterology. 2012; 59: 1102-1107
84. Schiphorst AH, Langenhoff BS, Maring J, Pronk A, Zimmerman DD. Transanal minimally invasive surgery: initial experience and short-Term functional results. Dis Colon Rectum. 2014; 57: 927-932
85. Heafner TA , Glasgow SC A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol. 2014; 5: 345-352
86. Im YC, Kim CW, Park S, Kim JC. Oncologic outcomes and proper surveillance after local excision of rectal cancer. J Korean Surg Soc. 2013; 84: 94-100
87. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007; 245: 726-733
88. Bujanda L, Cosme A, Gil I, Arenas-Mirave JI. Malignant colorectal polyps. World J Gastroenterol. 2010; 16: 3103-3111
89. Nusko G, Mansmann U, Partzsch U, et al. Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy. 1997; 29: 626-631
90. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985; 89: 328-336
91. Nivatvongs S, Rojanasakul A, Reiman HM, et al. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum. 1991; 34: 323-328
92. Kikuchi R, Takano M, Takagi K, et al. Management of early invasive colorectal cancer: risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995; 38: 1286-1295
93. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002; 45: 200-206
94. Tominaga K, Nakanishi Y, Nimura S, Yoshimura K, Sakai Y, Shimoda T. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum. 2005; 48: 92-100
95. Choi DH, Sohn DK, Chang HJ, Lim SB, Choi HS, Jeong SY. Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Dis Colon Rectum. 2009; 52: 438-445
96. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum. 2005; 48: 1588-1596
97. Williams JG, Pullan RD, Hill J, et al. Association of Coloproctology of Great Britain and Ireland. Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis. 2013; 15(suppl 2): 1-38
98. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844-857
99. Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Colorectal Dis. 2011; 13: e374-e378
100. Pickhardt PJ, Hain KS, Kim DH, Hassan C. Low rates of cancer or high-grade dysplasia in colorectal polyps collected from computed tomography colonography screening. Clin Gastroenterol Hepatol. 2010; 8: 610-615